PEG-IFN alpha but not ribavirin alters NK cell phenotype and function in patients with chronic hepatitis C
about
Effective induction of melanoma-antigen-specific CD8+ T cells via Vγ9γδT cell expansion by CD56(high+) Interferon-α-induced dendritic cells.Immune phenotype and function of natural killer and T cells in chronic hepatitis C patients who received a single dose of anti-MicroRNA-122, RG-101.A Novel Toll-Like Receptor 9 Agonist, MGN1703, Enhances HIV-1 Transcription and NK Cell-Mediated Inhibition of HIV-1-Infected Autologous CD4+ T Cells.Complementary Effects of Interleukin-15 and Alpha Interferon Induce Immunity in Hepatitis B Virus Transgenic Mice.Improvement of liver function parameters in advanced HCV-associated liver cirrhosis by IFN-free antiviral therapies.Immunological Analysis During Interferon-Free Therapy for Chronic Hepatitis C Virus Infection Reveals Modulation of the Natural Killer Cell Compartment.Altered effector functions of NK cells in chronic hepatitis C are associated with IFNL3 polymorphism.Natural Killer Cell Characteristics in Patients With Chronic Hepatitis B Virus (HBV) Infection Are Associated With HBV Surface Antigen Clearance After Combination Treatment With Pegylated Interferon Alfa-2a and Adefovir.Type I Interferon Responses by HIV-1 Infection: Association with Disease Progression and Control.Recovery of natural killer cells is mainly in post-treatment period in chronic hepatitis C patients treated with sofosbuvir plus ledipasvir
P2860
Q39104547-8BEB7FD3-BC0B-478D-87D0-1EEA39460D91Q40291580-0D69FB1F-0C42-4FFC-B52B-476F3DEE9FDBQ40336664-0EB6C106-8CFC-4F54-8E34-B76E553D8D10Q40605540-F424DD4A-6FAC-4364-9AB3-51331E4CC260Q41065311-723FFD59-28CA-4176-8DF4-66396CFF18C5Q41082823-BF6676B3-3EC1-40D8-8B15-E3A2BA0F2B51Q41190632-8B10F805-D0E5-46D1-A987-6AA0CFC75218Q41407146-9C9BCAA1-4C29-44FE-9C6A-2A590C7C5331Q47548056-A5CD76FF-BF30-40BE-8AB9-439C6D1AEECDQ58602166-D7B968B1-C548-4645-B778-86CA4EF52F37
P2860
PEG-IFN alpha but not ribavirin alters NK cell phenotype and function in patients with chronic hepatitis C
description
2014 nî lūn-bûn
@nan
2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
PEG-IFN alpha but not ribaviri ...... ients with chronic hepatitis C
@ast
PEG-IFN alpha but not ribaviri ...... ients with chronic hepatitis C
@en
type
label
PEG-IFN alpha but not ribaviri ...... ients with chronic hepatitis C
@ast
PEG-IFN alpha but not ribaviri ...... ients with chronic hepatitis C
@en
prefLabel
PEG-IFN alpha but not ribaviri ...... ients with chronic hepatitis C
@ast
PEG-IFN alpha but not ribaviri ...... ients with chronic hepatitis C
@en
P2093
P2860
P1433
P1476
PEG-IFN alpha but not ribaviri ...... ients with chronic hepatitis C
@en
P2093
Antoaneta A Markova
Birgit Bremer
Christoph Sarrazin
Eva Herrmann
Heiner Wedemeyer
Markus Cornberg
Michael P Manns
Natalie Filmann
Sebastian Lunemann
Thomas Berg
P2860
P304
P356
10.1371/JOURNAL.PONE.0094512
P407
P577
2014-04-21T00:00:00Z